在COPD患者的短效支气管扩展剂对静止呼吸能力反应中,呼吸障碍相关的临床重要的最小差异
Pierantonio Laveneziana1,2, David Hajage3, Nicolas Verger1
1UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, INSERM, Paris, France.
Pulmonology
|January 13, 2026
概括
在COPD患者中,使用支气管扩展剂后的呼吸能力 (IC) 变化更好地反映了症状缓解,而不是FEV1. 建议在IC中增加0.150L作为指导治疗的最小临床重要差异.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 在COPD患者中,支气管扩展剂诱导的呼吸能力 (IC) 变化的临床意义尚不清楚.
- 与1秒内强制呼气量 (FEV1) 不同,IC可能更好地反映了症状的改善,但尚未确定临床重要差异 (MCID) 的最小值.
研究的目的:
- 为了关联短效支气管扩展剂 (SABD) 诱导的呼吸障碍缓解在稳定的COPD患者同时IC变化.
- 在COPD患者中确定SABD诱导的IC变化的MCID.
主要方法:
- 106名稳定的COPD门诊患者在SABD给药前后接受了螺旋测量和胸膜造影.
- 用视觉模拟和利克特尺度来评估呼吸障碍.
- 使用基于ROC,基于差异和基于分布的方法估计了MCID.
主要成果:
- 64%的患者报告呼吸障碍改善,与IC变化有很强的相关性,与FEV1变化不同.
- 在ROC分析中,最佳IC值为0.125L (基线的5%).
- 建议的IC增加的MCID被确定为0.150 L.
结论:
- 在SABD管理后的IC变化与呼吸障碍缓解的关系比COPD患者休息时的FEV1变化更为密切.
- 增加0.150升的IC可以作为评估COPD管理和治疗策略中IC变化的临床实用性的实际基准.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Inhaled Medications
728
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
728
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K


